Archives for September 11, 2005

← 2005

Roche settles with Promega over PCR litigation

By  Wai Lang Chu

Roche Diagnostics has announced it has settled all litigation in the United States, Europe and Australia, with Promega concerning Polymerase Chain Reaction Technology (PCR), ending a decade of litigation between the two companies.

GS provides diabetes pipeline update.

By  Wai Lang Chu

According to a new report, the global diabetic population is set to double by 2030, with treatments currently falling way short of medical needs. The focus falls on impending products offering novel therapies to diabetics and for healthcare companies.

Pipetting system answers lab's requirements

By  Wai Lang Chu

CyBio launches its new pipetting system designed for newcomers to automation in small to medium sized laboratories. The system is CyBio's response to academia and biotech research requirements for a 96 well pipetting system.

Whatman feels effects of merger in first half

By Phil Taylor

Separations specialist Whatman is starting to reap the benefits of its acquisition of Schleicher & Schuell, but had a difficult first half to the year with the group's combined revenues down marginally compared to first-half 2004.

Biogen Idec cuts staff and sells assets

By Phil Taylor

US biotechnology company Biogen Idec has succumbed to the effects of having to withdraw its multiple sclerosis drug Tysabri (natalizumab) earlier this year, cutting 17 per cent of its workforce and putting manufacturing facilities up for sale in a bid...

Abuse-resistant opioid clears Phase III trial

By Phil Taylor

A novel painkiller in development at Pain Therapeutics - based on a technology that both improves dosing and prevents drug abuse - has done well in a Phase III clinical trial.

Stop 'cynical use' of drug studies, say researchers

By  Wai Lang Chu

Scientists in research and academia have called for the end to the pharmaceutical industry's 'cynical use' of drug studies and its subjects who are often misled into taking part.

Scientists discover control switch for immune system

By  Wai Lang Chu

Scientists in the US have discovered a cellular switch that controls immune system function. The research could lead to future drug treatment advancements for rheumatoid arthritis, multiple sclerosis and other autoimmune diseases.

Hike in drug withdrawals a myth, says Tufts

Quicker review times by the US Food and Drug Administration has not increased the number of prescription drugs withdrawn for safety reasons in the country, according to the Tufts Centre for the Study of Drug Development.